Previous 10 | Next 10 |
RANCHO CUCAMONGA, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, will be presenting at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 2:40 p.m. Eastern Time, New Y...
RANCHO CUCAMONGA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta Pharmaceuticals Inc. and Sandoz Inc., (collectively, “Mo...
RANCHO CUCAMONGA, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, will be presenting at the Raymond James Life Sciences and MedTech Healthcare Conference on Wednesday, June 19, 2019 at 4:10 p.m. Eastern Time, Ne...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this Read more ...
MannKind ( MNKD ) announced today that Afrezza has received approval from ANVISA . The long-awaited approval is now in the books, and investors are trying to determine exactly how big this news is. The reaction from the market has been muted thus far, and likely for good reason. The press rel...
Generic pharmaceuticals can be a tough industry, particular for smaller players that can experience dramatic fluctuations in quarterly earnings due to product shortages, price changes, and new competitive entrants, making these businesses exceptionally difficult for investors to value. Stabili...
RANCHO CUCAMONGA, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 8:30 a.m. Eastern Time,...
MannKind ( MNKD ) has its annual meeting on deck for May 14, 2019. While shareholders speculate about whether or not the company will break some news, the share price is down to $1.20. That share price could be a great entry point for active traders, as it rests at the low end of a trading ran...
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Earnings Conference Call May 09, 2019 05:00 PM ET Company Participants Jason Shandell - President, General Counsel and Director William Peters - Chief Financial Officer, Treasurer and Senior Vice President of Finance Conference Call...
RANCHO CUCAMONGA, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 at 3:40 p.m...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank of America Health Care Conference on Wednesday, M...
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2024. First Quarter ...